The Antitumor Activity of IMGN529, a CD37-Targeting...

Neoplasia 2017 / 09 Vol. 19; Iss. 9

The Antitumor Activity of IMGN529, a CD37-Targeting Antibody-Drug Conjugate, Is Potentiated by Rituximab in Non-Hodgkin Lymphoma Models

Hicks, Stuart W., Lai, Katharine C., Gavrilescu, L. Cristina, Yi, Yong, Sikka, Surina, Shah, Prerak, Kelly, Meghan E., Lee, Jenny, Lanieri, Leanne, Ponte, Jose F., Sloss, Callum M., Romanelli, Angela
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
19
Language:
english
Journal:
Neoplasia
DOI:
10.1016/j.neo.2017.06.001
Date:
September, 2017
File:
PDF, 1.35 MB
english, 2017
Conversion to is in progress
Conversion to is failed